Integrin alpha subunit

Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues – 15 to 23 amino acid residues in defined sequence

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530327, 530328, 530329, 530330, 514 13, 514 14, 514 15, 514 16, 514 17, C07K 504, C07K 704, A61K 3804

Patent

active

060574232

ABSTRACT:
The present invention relates to a novel integrin .alpha..sup.E subunit and its functional equivalents. The method for screening a molecular library to identify lead compounds which mimick the in vivo activity of an integrin .alpha..sup.E chain is disclosed. The invention further includes pharmaceutical compositions containing the isolated peptides, oligonucleotides encoding the peptides, vectors containing the oligonucleotides, and cell lines transfected with the vectors.

REFERENCES:
patent: 3652761 (1972-03-01), Weetal
patent: 4478946 (1984-10-01), Van der Merwe et al.
patent: 4554088 (1985-11-01), Whitehead et al.
patent: 5002873 (1991-03-01), St. John et al.
patent: 5120830 (1992-06-01), Santoro
patent: 5188959 (1993-02-01), Haberman
patent: 5206345 (1993-04-01), Masinovsky et al.
patent: 5211657 (1993-05-01), Yamada et al.
patent: 5432018 (1995-07-01), Dower et al.
patent: 5594120 (1997-01-01), Brenner et al.
patent: 5610281 (1997-03-01), Brenner et al.
Moller, P. et al., Rapid Communication-Monoclonal Antibody HML-1, a marker for Intraepithelial T Cells and Lymphomas Derived Thereof, Also Recognizes Hairy Cell Leukemia and Some B-cell Lymphomas. Amer. J. Path. 136: 509-512 (1990).
Visser, L. et al., Monoclonal Antibodies Reactive with Hairy Cell Leukemia, Blood 74: 320-325 (1989).
Cerf-Bensussan, N. et al., A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes, Eur. J. Immunol. 17: 1279-1285 (1987).
Kruschwitz, M. et al., Ber-ACT8: New monoclonal antibody to the mucosa lymphocyte antigen, J. Clin. Path 44, 636-645 (1991).
Pallesen, G. et al., Specificity of monoclonal antibody HML-1. Lancet 335: 537 (1990).
Visser, L. et al., Induction of B-cell chronic lymphocytic leukaemia and hairy cell leukaemia like phenotypes by phorbol ester treatment of normal peripheral blood B-cells. Brit. J. Haematol. 75: 359-365 (1990).
T. Springer, Adhesion receptors of the immune system. Nature, 346: 425-434 (1990).
S. Albelda, Biology of Disease--Role of Integrins and Other Cell Adhesion Molecules in Tumor Progression and Metastasis, Laboratory Investigation, 68: 4-17 (1993).
Cerf-Bensussan, N. et al., The human intraepithelial lymphocyte marker HML-1 is an integrin consisting of a .beta.7 subunit associated with a distinctive .alpha. chain, Eur. J. Immunol., 22,:273-277 (1992).
Krissansen, G.W. et al., Immunologic and structural relatedness of the integrin .beta..sub.7 complex and the human intraepithelial lymphocyte antigen HML-1. FEBS Letts. 296: 25-28 (1992).
A. Leff et al., Inflammation and cell-cell interactions in airway hyperresponsiveness. Am. Physiological Soc., 189-206 (1991).
R. Seth et al., ICAM-2 peptides mediate lymphocyte adhesion by binding to CDIIa/CD18 and CD49d/CD29 integrins, FEBS Letters 282: 193-196 (1991).
M. Conrad et al., A concise Review: Iron Absorption-The Mucin-Mobilferrin-Integrin Pathway. A Competitive Pathway for Metal Absorption, Am. J. Hematology, 42: 42-67 (1993).
S. Mette et al., Distribution of Integrin Cell Adhesion Receptors on Normal Bronchial Epithelial Cells and Lung Cancer Cells In Vitro and In Vivo, Am. J. Respir. Cell Mol. Biol., 8: 562-572 (1993).
E. Uhlmann et al., Antisense Oligonucleotides: A New Therapeutic Principle Chemical Reviews, Vol. 90(4): 543-584 (1990).
J. Holt et al., An Oligomer Complementary to c-myc MRNA Inhibits Proliferation of HL-60 Promyelocytic Cells and Induces Differentiation, Mol. Cell Biol., 8(2): 963-973 (1988).
M. Cooney et al., Site-Specific Oligonucleotide Binding Represses Transcription of the Human c-myc Gene In Vitro, Science, vol. 241: 456-459 (1988).
C. Helene et al., Oligodeoxynucleotides covalently linked to intercalating agents: a new class of gene regulatory substances, Biochimie, 67; 777-783 (1985).
W. James, Towards gene-inhibition therapy: a review of progress and prospects in the field of antiviral antisense nucleic acids and ribozymes. Antiviral Chem. & Chemo. 2(4): 191-214 (1991).
R. Weiss, Upping the Antisense Ante-Scientists bet on profits from reverse genetics, Science News, 139: 108-109 (1991).
M. Arnaout et al., Molecular cloning of the .alpha. subunit of human and guinea pig leukocyte adhesion Mol; Chromosomal localization and homology to the .alpha. subunits of integrins, Proc. Natl. Acad. Sci. USA, 85: 2776-2780 (1988).
T. Lallier et al., Inhibition of Neural Crest Cell Attachment by Integrin Antisense Oligonucleotides, Science, 259: 692-695 (1993).
A. Shatzman et al., Expression, Identification, and Characterization of Recombinant Gene Products in Escherichia coli, Methods in Enzymology, 152: 661-673 (1986).
Roberts, K. et al., The Mucosal T Cell Integrin Alpha -M-290-Beta-7 Recognizes a Ligand on Mucosal Epithelial Cell Lines, Eur. J. Immunol. 23 (7): 1630-1635 (1993).
Shaw, S. et al., Molecular Cloning of the Human Mucosal Lymphocyte Intergrin Alpha-E Subunit: Unusual Structure and Restricted RNA Distribution, Journal of Biological Chemistry, 269(8): 6016-6025 (1994).
Tidd, D., A Potential Role for Antisense Oligonucleotide Analogues in the Development of Oncogene Targeted Cancer Chemotherapy, Anticancer Research 10: 1169-1182 (1990).
Wu-Pong, S., Oligonucleotides: Opportunities for Drug Therapy and Research, Pharm. Tech.:102-114 (1994).
Westermann, P., et al., Inhibition of expression of SV40 virus large T-antigen by antisense oligodeoxyribonucleotides, Biomed. Biochim. Acta 48(1): 85-93 (1989).
"Binding of Intraepithelial Lymphocytes to Colon Cancer Cells is Mediated by HMLI and LFA1, A685" Roberts and O'Connell, K.C. Ebert, Depts. Of Medicine and Surgery, UMDMJ-Robert Wood Johnson Medical School, New Brunswick, NJ, (Apr. 1992) (Typed version also enclosed as original is hard to read).
"Reactivity of Monoclonal Antibody B-ly7 with a Subset of Activited T Cells and T-Cell Lymphomas," Visser, Dabbagh, and Poppema, Hematol Pathol 6(1):37-42 (1992).
Harris, W.J., et al., "Therapeutic Antibodies--the Comingof Age,"TIBTECH, 11:42-44, Feb. 1993.
Osband, M.E., et al., "Problems in the Investigational Study and Clinical Use of Cancer Immunotherapy," Immunology Today, 11(6):193-195, 1990.
Waldmann, T.A., "Monoclonal Antibodies in Diagnosis and Therapy," Science, 252:1657-1662, Jun. 1991.
Shirayoshi, Y. et al., "N-Linked Oligosaccharides Are Not Involved in the Function of a Cell-Cell Binding Glycoprotein E-Cadherin." Cell Structure and Function, 11:245-252, 1986.
Karecla, P.I., et al., "Recognition of E-Cadherin on Epithelial Cells by the Mucosal T Cell Integrin .alpha..sub.M290 .beta.7 (.alpha.E.beta.7)," Eur. J. Immunol., 25:852-856, 1995.
Geiger, B. et al., "Cadherins," (1992) Annual Review of Cell Biology 8:307-32.
Takeichi M., "Cadherin Cell Adhesion Receptors as a Morphogenetic Regulator," (1991) Science 251:1451-1455.
Kemler, R., "From Cadherins to Catenins: Cytoplasmic Protein Interactions and Regulation of Cell Adhesion," (1993) Trends in Gastroenterology 9:317-321.
Nose, A. et al., "Localization of Specificity Determining Sites in Cadherin Cell Adhesion Molecules," (1990) Cell 61:147-155.
Kaiserlain D. et al., Expression, Function, and Regulation of the Intercellular Adhesion Molecule-1 (ICAM-1) on Human Intestinal Epithelial Cell Lines, (1991) Eur. J. of Immunol. 21(10):2415-2421.
Shimoyama Y. et al., "Cadherin Cell -Adhesion Molecules in Human Epithelial Tissues and Carcinomas," (1989) Cancer Research 49(8):2128-2133.
Vestweber D. et al., "Identification of a Putative Cell Adhesion Domain of Uvomorulin," (1985) EMBO J. 4:3393-3398.
Springer, T., "The Sensation and Regulation of Interactions with the Extracellular Environment: The Cell Biology of Lymphocyte Adhesion Receptors," (1990) Annual Review of Cell Biol. 6:359-402.
Cepek, K. et al., Adhesion Between Epithelial Cells and T Lymphocites Mediated by E-Cadherin and the .alpha..sup.E .beta.7 Integrin, Nature, vol. 372, Nov. 10, 1994, pp. 190-193.
T. Ferguson et al., Two integrin-binding peptides abrogate T cell-mediated immune response in vivo, Proc. Natl. Acad. Sci. USA, vol. 88: 8072-8076, Sep. 1991.
D. Taylor et al., A Peptide Corresponding to GPIIb.alpha. 300-312, a Presumptive

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Integrin alpha subunit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Integrin alpha subunit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Integrin alpha subunit will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1594782

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.